Add Yahoo as a preferred source to see more of our stories on Google. Singer/ Trumpet Player & Band Leader Rob Dehlinger of the Alpha Rhythm Kings joined host Rachael Maurer to chat about their new ...

Rhythm Pharmaceuticals faces a pivotal period, as IMCIVREE awaits potential FDA approval for acquired hypothalamic obesity in December 2025. RYTM's market opportunity could double or triple with AHO ...

I maintain my Buy rating on Rhythm Pharmaceuticals due to its leadership in rare genetic obesity treatments. The company’s innovative therapies address significant unmet needs, supporting long-term ...

Singer/trumpet player and band leader Rob Dehlinger of the Alpha Rhythm Kings joined host Rachael Maurer to chat about their new music and upcoming shows. Watch the clip below to see a live ...